ClinVar Genomic variation as it relates to human health
NM_005476.7(GNE):c.2135T>C (p.Met712Thr)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_005476.7(GNE):c.2135T>C (p.Met712Thr)
Variation ID: 6025 Accession: VCV000006025.39
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 9p13.3 9: 36217399 (GRCh38) [ NCBI UCSC ] 9: 36217396 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 3, 2013 Oct 8, 2024 Mar 23, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_005476.7:c.2135T>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_005467.1:p.Met712Thr missense NM_001128227.3:c.2228T>C MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001121699.1:p.Met743Thr missense NM_001190383.3:c.1913T>C NP_001177312.1:p.Met638Thr missense NM_001190384.3:c.1805T>C NP_001177313.1:p.Met602Thr missense NM_001190388.2:c.1958T>C NP_001177317.2:p.Met653Thr missense NM_001374797.1:c.1982T>C NP_001361726.1:p.Met661Thr missense NM_001374798.1:c.1958T>C NP_001361727.1:p.Met653Thr missense NC_000009.12:g.36217399A>G NC_000009.11:g.36217396A>G NG_008246.1:g.64646T>C LRG_1197:g.64646T>C LRG_1197t1:c.2228T>C LRG_1197p1:p.Met743Thr LRG_1197t2:c.2135T>C LRG_1197p2:p.Met712Thr - Protein change
- M712T, M743T, M602T, M638T, M653T, M661T
- Other names
- -
- Canonical SPDI
- NC_000009.12:36217398:A:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00002
Exome Aggregation Consortium (ExAC) 0.00003
The Genome Aggregation Database (gnomAD), exomes 0.00004
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
GNE | - | - |
GRCh38 GRCh37 |
1053 | 1131 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (13) |
criteria provided, multiple submitters, no conflicts
|
Mar 23, 2024 | RCV000006396.23 | |
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Nov 18, 2022 | RCV000443895.17 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Jan 28, 2024 | RCV000763615.11 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 22, 2021 | RCV001705582.2 | |
GNE-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Aug 5, 2024 | RCV004748503.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
GNE myopathy
GNE myopathy Sialuria
Affected status: unknown
Allele origin:
germline
|
Baylor Genetics
Accession: SCV001163609.1
First in ClinVar: Mar 01, 2020 Last updated: Mar 01, 2020 |
|
|
Pathogenic
(Dec 20, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
GNE myopathy
Affected status: unknown
Allele origin:
unknown
|
Myriad Genetics, Inc.
Accession: SCV001194231.2
First in ClinVar: Apr 06, 2020 Last updated: Jul 06, 2020 |
Comment:
NM_005476.5(GNE):c.2135T>C(M712T) is classified as pathogenic in the context of GNE myopathy. Sources cited for classification include the following: PMID 21873062, 11528398, 12497639, 20300792 and 15987957. … (more)
NM_005476.5(GNE):c.2135T>C(M712T) is classified as pathogenic in the context of GNE myopathy. Sources cited for classification include the following: PMID 21873062, 11528398, 12497639, 20300792 and 15987957. Classification of NM_005476.5(GNE):c.2135T>C(M712T) is based on the following criteria: This is a well-established pathogenic variant in the literature that has been observed more frequently in patients with clinical diagnoses than in healthy populations. Please note: this variant was assessed in the context of healthy population screening.‚Äã (less)
|
|
Pathogenic
(Jul 22, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Sialuria
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV001810459.1
First in ClinVar: Sep 26, 2021 Last updated: Sep 26, 2021 |
Sex: mixed
|
|
Pathogenic
(Mar 22, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
GNE myopathy
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002318651.1
First in ClinVar: Apr 02, 2022 Last updated: Apr 02, 2022 |
Comment:
Same or different nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000006025, PMID:11528398). … (more)
Same or different nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000006025, PMID:11528398). The variant was co-segregated with Nonaka myopathy in multiple affected family members with additional meioses meeting moderate evidence levels (PMID: 11528398). Functional assays showed that the variant had moderate level of impact on gene/protein function (PMID: 15670773, 15147877). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.756>=0.6, 3CNET: 0.836>=0.75). A missense variant is a common mechanism. It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.0000398). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Seizure (present)
|
|
Pathogenic
(Nov 18, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000513166.6
First in ClinVar: Mar 08, 2017 Last updated: Dec 03, 2022 |
Comment:
Published functional studies demonstrate reduced activity compared to wild-type, presumably due to the introduction of an additional phosphorylation/O-GlcNAcylation site as the M743T variant shows increased … (more)
Published functional studies demonstrate reduced activity compared to wild-type, presumably due to the introduction of an additional phosphorylation/O-GlcNAcylation site as the M743T variant shows increased O-GlcNAcylation as compared to wild-type (Bennmann et al., 2016); The majority of missense variants in this gene are considered pathogenic (HGMD); A founder variant common in the Persian Jewish population (Eisenberg et al., 2001); This variant is associated with the following publications: (PMID: 24136589, 22975760, 20300792, 27023225, 23278550, 17673919, 22322304, 15670773, 15147877, 19917666, 22507750, 21873062, 23238814, 27037841, 15987957, 11528398, 25966635, 12473780, 27671536, 24264357, 28267778, 15136692, 34426522, 31589614, 19787087) (less)
|
|
Pathogenic
(Jul 27, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Sialuria
GNE myopathy
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000894469.2
First in ClinVar: Mar 31, 2019 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
GNE myopathy
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Hadassah Hebrew University Medical Center
Accession: SCV004099503.1
First in ClinVar: Nov 04, 2023 Last updated: Nov 04, 2023 |
|
|
Pathogenic
(Oct 13, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002024879.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Feb 20, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
GNE myopathy
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV004813788.1
First in ClinVar: Apr 15, 2024 Last updated: Apr 15, 2024 |
Comment:
Variant summary: GNE c.2228T>C (p.Met743Thr) also known as p.Met712Thr, results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico … (more)
Variant summary: GNE c.2228T>C (p.Met743Thr) also known as p.Met712Thr, results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 251286 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in GNE causing Inclusion Body Myopathy 2 (4e-05 vs 0.0011), allowing no conclusion about variant significance. c.2228T>C has been reported as the common Persian Jewish mutation in the literature in multiple individuals affected with Inclusion Body Myopathy 2 from Middle East (example, Argov_2003). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in impared GNE function and accumulated Glycosphingolipid levels in both primary fibroblasts from patients and knock-in mice with homozygous p.Met743Thr (Patzel_2014). The following publications have been ascertained in the context of this evaluation (PMID: 12743242, 24136589). ClinVar contains an entry for this variant (Variation ID: 6025). Based on the evidence outlined above, the variant was classified as pathogenic. (less)
|
|
Pathogenic
(Nov 05, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
GNE myopathy
(Autosomal recessive inheritance)
Affected status: unknown
Allele origin:
germline
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Accession: SCV004848011.1
First in ClinVar: Apr 20, 2024 Last updated: Apr 20, 2024 |
Comment:
The p.Met743Thr variant in GNE (also reported in literature as Met712Thr) has been reported in >50 individuals with inclusion body myopathy in the homozygous and … (more)
The p.Met743Thr variant in GNE (also reported in literature as Met712Thr) has been reported in >50 individuals with inclusion body myopathy in the homozygous and compound heterozygous state and segregated with disease in >50 affected individuals from multiple families (Eisenberg 2001 PMID: 11528398, Broccolini 2002 PMID: 12473780, Grandis 2010 PMID: 20300792, Khademian 2013 PMID: 23278550). It has been found in the homozygous state in some apparently asymptomatic family members which could give some evidence to reduced penetrance (Argov 2003 PMID: 1274324). It has also been identified in 0.001% (1/68034) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 6025). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In vitro and in vivo functional studies support some impact on protein function, including increased glycosphingolipids in cells (Salama 2005 PMID: 15670773, Sparks 2005 PMID: 15987957, Patzel 2013 PMID: 24136589). Mouse models homozygous for the Met743Thr variant showed >90% lethality, severe hematuria, proteinuria and glomerulopathy, though in a later study variable phenotypes of mice were found (Kakani 2012 PMID: 22322304, Sela 2013 PMID: 23238814, Patzel 2013 PMID: 24136589). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive GNE myopathy. ACMG/AMP Criteria applied: PP1_Strong, PM3, PS3_Moderate, PM2_Supporting, PP3. (less)
|
|
Pathogenic
(Apr 10, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000331555.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 18
Sex: mixed
|
|
Pathogenic
(Dec 09, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV001714897.1
First in ClinVar: Jun 15, 2021 Last updated: Jun 15, 2021 |
Comment:
PS3, PS4_moderate, PM2, PM3, PP5
Number of individuals with the variant: 1
|
|
Pathogenic
(Jan 28, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Sialuria
GNE myopathy
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000823050.6
First in ClinVar: Oct 10, 2018 Last updated: Feb 28, 2024 |
Comment:
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 743 of the GNE protein (p.Met743Thr). … (more)
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 743 of the GNE protein (p.Met743Thr). This variant is present in population databases (rs28937594, gnomAD 0.004%). This missense change has been observed in individuals with inclusion body myopathy (PMID: 11528398, 20300792, 23278550). It is commonly reported in individuals of Persian ancestry (PMID: 11528398, 20300792, 23278550). This variant is also known as c.2186T>C (p.Met712Thr). ClinVar contains an entry for this variant (Variation ID: 6025). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GNE protein function. Experimental studies have shown that this missense change affects GNE function (PMID: 15147877, 15670773). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Mar 23, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
GNE myopathy
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004199375.2
First in ClinVar: Dec 30, 2023 Last updated: Jun 17, 2024 |
|
|
Pathogenic
(Nov 01, 2014)
|
no assertion criteria provided
Method: clinical testing
|
Inclusion body myopathy 2
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Sema4, Sema4
Accession: SCV000196518.1
First in ClinVar: Jan 08, 2015 Last updated: Jan 08, 2015 |
Comment:
8 patients from 7 non-Jewish Persian families were homozygous for this variant
Number of individuals with the variant: 8
Family history: yes
Sex: mixed
Geographic origin: Iran
Comment on evidence:
age of onset 19-30
|
|
Pathogenic
(May 11, 2004)
|
no assertion criteria provided
Method: literature only
|
NONAKA MYOPATHY
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000026578.3
First in ClinVar: Apr 04, 2013 Last updated: Jan 06, 2017 |
Comment on evidence:
In 47 Middle Eastern Jewish families, Eisenberg et al. (2001) found that affected individuals with Nonaka myopathy (NM; 605820), which the authors called hereditary inclusion … (more)
In 47 Middle Eastern Jewish families, Eisenberg et al. (2001) found that affected individuals with Nonaka myopathy (NM; 605820), which the authors called hereditary inclusion body myopathy (HIBM), had a 2186T-C transition in exon 12 of the GNE gene, resulting in a met712-to-thr (M712T) amino acid change in the kinase domain of the protein. In 2 second cousins from an Italian family diagnosed with HIBM, Broccolini et al. (2002) identified compound heterozygosity for mutations in the GNE gene: M712T and a novel mutation (M171V; 603824.0016). The authors noted that it was the first report of the M712T mutation in patients of non-Middle Eastern descent. Argov et al. (2003) identified homozygosity for the M712T mutation in 129 Middle Eastern patients diagnosed with HIBM from 55 families. Eleven patients had atypical features: 5 had involvement of the quadriceps muscle, 2 patients did not have distal weakness, 3 patients had facial weakness, and 1 patient had perivascular inflammation. There were 5 unaffected individuals with the homozygous mutation from 5 different HIBM families, including 2 who were 50 and 68 years old. The families included Middle Eastern Jews, Karaites, and Arab Muslims of Palestinian and Bedouin origin. Argov et al. (2003) offered a detailed historical perspective of the different cultures, and concluded that this founder mutation is approximately 1,300 years old and is not limited to those of Jewish descent. In a Japanese patient with Nonaka myopathy, Tomimitsu et al. (2004) identified compound heterozygosity for the M712T mutation and the A631V mutation (603824.0015). The findings indicated that Nonaka myopathy and what was previously called hereditary inclusion body myopathy are identical disorders. (less)
|
|
Pathogenic
(Sep 16, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Nonaka myopathy
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV001458426.1
First in ClinVar: Jan 02, 2021 Last updated: Jan 02, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
GNE myopathy
Affected status: unknown
Allele origin:
germline
|
FirmaLab, FirmaLab
Accession: SCV000106038.1
First in ClinVar: Mar 16, 2017 Last updated: Mar 16, 2017 |
|
|
Pathogenic
(Feb 11, 2019)
|
no assertion criteria provided
Method: research
|
GNE myopathy
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
inherited
|
Department of Rehabilitation Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea
Accession: SCV000882763.1
First in ClinVar: Sep 25, 2018 Last updated: Sep 25, 2018 |
|
|
Pathogenic
(Feb 05, 2020)
|
no assertion criteria provided
Method: clinical testing
|
GNE myopathy
Affected status: yes
Allele origin:
germline
|
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
Accession: SCV001190834.1
First in ClinVar: Mar 29, 2020 Last updated: Mar 29, 2020 |
|
|
Pathogenic
(Aug 05, 2024)
|
no assertion criteria provided
Method: clinical testing
|
GNE-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005360219.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
The GNE c.2228T>C variant is predicted to result in the amino acid substitution p.Met743Thr. This variant is also known as (g.36217396A>G, c.2135T>C, p.Met712Thr with alternative … (more)
The GNE c.2228T>C variant is predicted to result in the amino acid substitution p.Met743Thr. This variant is also known as (g.36217396A>G, c.2135T>C, p.Met712Thr with alternative transcript NM_005476.5). This variant has been reported as a pathogenic founder variant in certain populations (Persian-Jewish) and is well documented to be causative for GNE myopathy (Eisenberg et al. 2001. PubMed ID: 11528398; Mori-Yoshimura et al. 2012. PubMed ID: 22507750; Haghighi et al. 2016. PubMed ID: 25966635). Enzymatic studies and mouse models with the c.2228T>C variant support the pathogenicity of this variant (Sparks et al. 2005. PubMed ID: 15987957; Patzel et al. 2014. PubMed ID: 24136589). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD and is interpreted as pathogenic in ClinVar by many outside laboratories (https://www.ncbi.nlm.nih.gov/clinvar/variation/6025/). This variant is interpreted as pathogenic for recessive GNE myopathy. (less)
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
GNE myopathy
Affected status: unknown
Allele origin:
germline
|
GeneReviews
Accession: SCV000058062.4
First in ClinVar: Apr 04, 2013 Last updated: Oct 01, 2022 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
GNE Myopathy. | Adam MP | - | 2020 | PMID: 20301439 |
Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5'UTR and founder allele. | Zhu W | Journal of human genetics | 2017 | PMID: 27829678 |
Non-specific accumulation of glycosphingolipids in GNE myopathy. | Patzel KA | Journal of inherited metabolic disease | 2014 | PMID: 24136589 |
Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy). | Cho A | Journal of neurology, neurosurgery, and psychiatry | 2014 | PMID: 24027297 |
Prevalence of GNE p.M712T and hereditary inclusion body myopathy (HIBM) in Sangesar population of Northern Iran. | Khademian H | Clinical genetics | 2013 | PMID: 23278550 |
The Gne M712T mouse as a model for human glomerulopathy. | Kakani S | The American journal of pathology | 2012 | PMID: 22322304 |
Biochemical characterization of the M712T-mutation of the UDP-N-acetylglucosamine 2-epimerase/N-acetyl-mannosaminekinase in hereditary inclusion body myopathy. | Weidemann W | Neuromuscular disorders : NMD | 2011 | PMID: 21873062 |
The spectrum of GNE mutations: allelic heterogeneity for a common phenotype. | Grandis M | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2010 | PMID: 20300792 |
Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy. | Sparks SE | Glycobiology | 2005 | PMID: 15987957 |
No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation. | Salama I | Biochemical and biophysical research communications | 2005 | PMID: 15670773 |
The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy. | Hinderlich S | FEBS letters | 2004 | PMID: 15147877 |
Distal myopathy with rimmed vacuoles (DMRV): new GNE mutations and splice variant. | Tomimitsu H | Neurology | 2004 | PMID: 15136692 |
Hereditary inclusion body myopathy: the Middle Eastern genetic cluster. | Argov Z | Neurology | 2003 | PMID: 12743242 |
Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps. | Eisenberg I | Human mutation | 2003 | PMID: 12497639 |
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene. | Broccolini A | Neurology | 2002 | PMID: 12473780 |
Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. | Nishino I | Neurology | 2002 | PMID: 12473753 |
The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. | Eisenberg I | Nature genetics | 2001 | PMID: 11528398 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GNE | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs28937594 ...
HelpRecord last updated Oct 13, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.